Overview
What is Targetcancer Foundation Inc?
Targetcancer Foundation Inc is a nonprofit organization situated in Cambridge, Massachusetts. Their primary focus is to advocate for and fund research into rare cancers, aiming to improve treatment options and patient support. In 2020, they launched the TCF-001 TRACK clinical trial, a 400-patient study on genomics and precision medicine in rare cancers. This initiative provides patients with personalized genomic data and treatment recommendations, while also generating valuable research data. In 2022, Targetcancer Foundation organized two significant scientific meetings, promoting collaboration and information-sharing among key stakeholders in the rare cancer field. With a small team of 4 employees, this organization is dedicated to advancing the fight against rare cancers.
Official website here: www.targetcancer.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 96% (Four-Star out of Four Star rating)
Targetcancer Foundation Inc has received an impressive Four-Star rating from Charity Navigator, reflecting a high level of accountability and financial health. The charity's overall score of 96% is derived entirely from its strong performance in Accountability & Finance, showcasing meticulous management and transparency in its operations. Key indicators include a fully independent board and excellent scores in areas such as financial oversight, conflict of interest policies, and asset management.
User feedback highlights the organization's positive impact and dedicated team. A review from Jonny Imerman of Imerman Angels commended the foundation's mission and the quality of the team, indicating a strong partnership and collaborative spirit in their work. This recognition from external contributors suggests that the foundation is well-regarded within the nonprofit community.
While the financial metrics demonstrate solid performance, there are no noted limitations in the available data. Overall, Targetcancer Foundation Inc appears to be a reliable and effective organization committed to its cause.
This AI summary has been generated from information found on Charity Navigator and Great Nonprofits.
Is Targetcancer Foundation Inc legitimate?
Targetcancer Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Targetcancer Foundation Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $221,934
Professional Fundraising Fees: $0
Other Salaries and Wages: $88,928
For more financial information, click here
Official website here: www.targetcancer.org
What is the mission statement of Targetcancer Foundation Inc?
The Targetcancer Foundation Inc's mission is centered around promoting advancements in the treatment of rare cancers. They accomplish this by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients. The organization directly supports initiatives at the forefront of cancer treatment, including operating a rare cancer precision medicine clinical trial and launching a 400-patient study called TCF-001 TRACK. This trial provides patients with personalized genomic data and treatment recommendations, while also generating valuable research data on rare cancers. Moreover, Targetcancer Foundation organizes scientific meetings, such as the Think Tank on Advancing Precision Medicine in Rare Cancers and the Think Tank on Advancing Gastroesophageal Cancer Research, to promote collaboration, information-sharing, and idea generation within the field.
Official website here: www.targetcancer.org
Who is the CEO of Targetcancer Foundation Inc?
James M Palma is the CEO of Targetcancer Foundation Inc The CEO's salary of Targetcancer Foundation Inc is $163,594 and their total compensation is $164,990.
Official website here: www.targetcancer.org
What is the revenue of Targetcancer Foundation Inc?
Targetcancer Foundation Inc's revenue in 2024 was $676,451.
Official website here: www.targetcancer.org
Who are the executives of Targetcancer Foundation Inc and what are their salaries?
The average compensation at Targetcancer Foundation Inc during 2024 was $77,716. There are 4 employees and 30 volunteers at Targetcancer Foundation Inc.
Here are 11 key members and their salaries (Targetcancer Foundation Inc's CEO's salary is $163,594 and their total compensation is $164,990):
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $39,931
- Related: $0
- Other: $13,946
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $163,594
- Related: $0
- Other: $1,396
Official website here: www.targetcancer.org
Where can I find the form 990 for Targetcancer Foundation Inc?
Targetcancer Foundation Inc's most recent form 990 was submitted in 2024 and can be accessed here.
Official website here: www.targetcancer.org
Learn more at the official website: www.targetcancer.org
Mission Statement of Targetcancer Foundation Inc
Targetcancer Foundation Inc is committed to promoting the advancement of lifesaving treatment protocols for rare cancers. This nonprofit organization achieves its mission by directly supporting innovative research initiatives, fostering collaborations, and raising awareness among scientists, clinicians, and patients. The Foundation's primary objective is to fund projects that are at the forefront of cancer treatment, with a specific focus on rare cancers.
In pursuit of its mission, Targetcancer Foundation Inc launched the TCF-001 TRACK clinical trial in 2020. This 400-patient study investigates genomics and precision medicine in rare cancers, providing patients with critical genomic data about their cancer and tailored treatment recommendations from leading experts in the field. The trial also contributes to the generation of valuable research data on rare cancers. Additionally, the Foundation conducts scientific meetings, such as the Think Tank on Advancing Precision Medicine in Rare Cancers and the Think Tank on Advancing Gastroesophageal Cancer Research. These events bring together key stakeholders, including clinicians, researchers, government representatives, industry professionals, and patients and advocates, to promote collaboration, information-sharing, and idea generation. These initiatives aim to define research priorities, foster new collaborative efforts, and ultimately drive progress in the field of rare cancer treatment.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
TargetCancer Foundation Inc significantly impacts the landscape of rare cancer treatment and research by raising awareness and supporting critical initiatives aimed at understanding and treating these unique diseases. Through the operation of the TCF-001 TRACK clinical trial, the foundation provides invaluable personalized genomic data to patients with rare cancers, guiding their treatment options based on the latest scientific insights. This initiative not only benefits participants by offering tailored recommendations from leading experts but also contributes to a broader pool of research data, enhancing knowledge about rare cancers.
In addition to its clinical trial efforts, TargetCancer Foundation fosters collaboration through major scientific meetings, such as the Think Tank on Advancing Precision Medicine in Rare Cancers. These gatherings connect key stakeholders, including clinicians, researchers, and industry professionals, enabling the exchange of ideas and the establishment of research priorities aimed at advancing treatment protocols. By promoting interdisciplinary cooperation, the foundation drives innovation and accelerates progress in the quest for effective therapies for rare cancers.
Through these programs and initiatives, TargetCancer Foundation not only supports patients and their families facing the challenges of rare cancers but also lays the groundwork for future breakthroughs in the field, ensuring that rare cancer research remains a priority in medical science.
This information is meant to be a general summary of Targetcancer Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2024.
- Investment Income: $2,338
- Gross Receipts: $676,451
Assets and Liabilities:
- Total Assets: $645,131
- Total Liabilities: $0
- Net Assets: $645,131
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2009
Principal Officer
James Palma
Website
www.targetcancer.orgNTEE Category
Code: H30 - Medical research
If you are a representative of Targetcancer Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.